期刊文献+

卡莫氟固体脂质纳米粒的制备及工艺研究 被引量:2

Preparation and Its Technology of Solid Lipid Nanoparticles of Carmofur
原文传递
导出
摘要 目的:制备卡莫氟固体脂质纳米粒并考察其药剂性质。方法:采用高压均质法制备卡莫氟固体脂质纳米粒混悬液,以单因素考察和正交设计法筛选处方和工艺,并考察其形态、粒径、载药量及包封率。结果:优选出的较佳处方大豆卵磷脂、泊洛沙姆188、吐温-80和硬脂酸用量分别为8.0、12.0、1.0、7.5mg·mL-1;所制得的固体脂质纳米粒为圆整的实体粒子,表面光滑,平均粒径为78.7nm,载药量为23.47%,包封率为82.33%。结论:高压均质法可用于卡莫氟类脂溶性药物固体脂质纳米粒的制备。 OBJECTIVE: To prepare solid lipid nanoparticles(SLNs) of carmofur and to study the pharmaceutical property of it. METHODS: The SLNs of carmofur were prepared by the high pressure homogenization method; the formula and technology were optimized by the single factor exploration and orthogonal design, and the shape, particle size, loading capacity, and the encapsulation efficiency were investigated. RESULTS: The optimized preparation conditions for SLNs of carmofur were as follows: the amount of soybean lecithin, poloxamer 188, tween - 80 and stearic acid were 8.0, 12.0, 1.0, and 7.5mg · mL^-1 respectively; and the obtained solid lipid nanoparticles were round, smooth solid particles with particle size of 78.7 nm, loading capacity of 23.47% and encapsulation efficiency of 82.33%. CONCLUSION: The high pressure homogenization method is applicable for the preparation of SLNs of lipid soluble carmofur.
作者 周燕萍
出处 《中国药房》 CAS CSCD 北大核心 2007年第25期1952-1954,共3页 China Pharmacy
关键词 卡莫氟 固体脂质纳米粒 高压均质法 制备工艺 单因素 正交设计 包封率 Carmofur Solid lipid nanoparticles High pressure homogenization method Preparation technology Single factor Orthogonal design Encapsulation efficiency
  • 相关文献

参考文献7

二级参考文献97

  • 1李新中,刘韶,雷鹏,许利敏.薄膜-超声法制备黄芩苷固体脂质纳米粒的工艺研究[J].中国医学工程,2004,12(5):21-23. 被引量:11
  • 2何军,奉建芳,庞家忠,侯世祥.星点设计-效应面法优化水飞蓟素固体脂质纳米粒的制备[J].中国医药工业杂志,2005,36(1):18-21. 被引量:15
  • 3刘建平,杜志永,朱丽.丹参酮Ⅱ_A固体脂质纳米粒的体外释药和大鼠肠吸收特性的研究[J].中国药理学通报,2005,21(2):186-190. 被引量:19
  • 4靳和国,胡佳文,吴晓华.泊洛沙姆在扑热息痛片中的应用[J].中国医药工业杂志,1995,26(4):157-158. 被引量:3
  • 5Taguchi T. Review of a new antimetabolic agent 1-hexylcar-bamoyl-5-fluorouracil (HCFU) [J]. Recent Results Cancer Res, 1980, 70:125 - 132.
  • 6Maehara Y, Anai H, Kusumoto H, et al. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbarnoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil [J]. Dis Colon Rectum,1988, 31(1) :62 - 67.
  • 7Mastrobattista E, Koning GA, Storm G. Immunoliposomes for the targeted delivery of antitumor drugs [J].Adv Drug Deliv Rev, 1999, 40(1 - 2) :103 - 127.
  • 8Crosasso P, Brusa P, Dosio F, et al. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs [J] .J Pharm Sci, 1997, 86(7) :832 - 839.
  • 9Martin F J, Papahadjopoulos D. Irreversible coupling of immunoglobulin fragments to preformed vesicles [ J ]. J Biol Chem, 1982,257:286.
  • 10Suenaga M. 5-FU and HCFU concentrations in serum and tissues in hepatocellular carcinoma after HCFU oral administration [J]. Gan No Rinsho, 1988, 34(6) :744 -748.

共引文献85

同被引文献9

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部